Article
Patient monitoring through liquid biopsies using circulating tumor DNA
3 May 2017
Abstract excerpt
Tumors release components such as circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and tumor-derived extracellular vesicles into the circulation. Multiple studies have demonstrated that molecular information about tumors and metastases can be extracted from these factors, which are therefore frequently referred to as "liquid biopsies." Liquid biopsies allow the longitudinal monitoring of tumor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
